Chapter 4. Cardiovascular Toxicity of Antitumor Drugs: Dimensions of the Problem in Children

  1. Giorgio Minotti
  1. Rebecca Scully1 and
  2. Steven E. Lipshultz2

Published Online: 9 APR 2010

DOI: 10.1002/9780470660379.ch4

Cardiotoxicity of Non-Cardiovascular Drugs

Cardiotoxicity of Non-Cardiovascular Drugs

How to Cite

Scully, R. and Lipshultz, S. E. (2010) Cardiovascular Toxicity of Antitumor Drugs: Dimensions of the Problem in Children, in Cardiotoxicity of Non-Cardiovascular Drugs (ed G. Minotti), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470660379.ch4

Editor Information

  1. University Campus Bio-Medico, CIR and Drug Sciences, and Alberto Sordi Foundation-Research Institute on Aging, Via Alvaro del Portillo 21, 00128 Rome, Italy

Author Information

  1. 1

    Department of Pediatrics, University of Miami Leonard M. Miller School of Medicine, P.O. Box 016820, Miami, FL 33101, USA

  2. 2

    University of Miami, Leonard M. Miller School of Medicine, Holtz Children's Hospital of the University of Miami/Jackson Memorial Medical Center and the Sylvester Comprehensive Cancer Center, Department of Pediatrics, P.O. Box 016820, Miami, FL 33101, USA

Publication History

  1. Published Online: 9 APR 2010
  2. Published Print: 16 APR 2010

ISBN Information

Print ISBN: 9780470772744

Online ISBN: 9780470660379

SEARCH

Keywords:

  • antitumor drugs cardiovascular toxicity - problems in children;
  • drugs with known cardiotoxicity - anthracyclins;
  • cardiotoxicity risk factors - radiation;
  • cardioprotective strategies;
  • drug-induced cardiomyopathy monitoring - electrocardiography;
  • cardiac follow up - in childhood cancer survivors;
  • cardiotoxic chemotherapeutic agents

Summary

This chapter contains sections titled:

  • Introduction

  • Drugs with known Cardiotoxicity

  • Additive Cardiotoxicity Risk Factors

  • Cardioprotective Strategies

  • Cardiovascular Monitoring

  • Cardiac Follow-Up in Survivors of Childhood Cancer

  • Conclusion

  • References